Russell Investments Group’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Russell Investments Group’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-40,062	Closed	-$492K	–	3436
2022 Q4	$492K	Buy	+40,062	New	+$955K	﹤0.01%	2293

Russell Investments Group's CINC Position: Q1 2023 in Review

Russell Investments Group sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 40,062 shares — an estimated $492K sold.

Russell Investments Group first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $492K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Russell Investments Group reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Russell Investments Group sold 40,062 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $492K.
Russell Investments Group first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Russell Investments Group's CinCor Pharma, Inc. Common Stock position peaked at $492K in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Russell Investments Group's 13F filing for Q1 2023, filed 9 May 2023.